This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Mon May 20, 2013 4:46 am


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 4 posts ] 
Author Message
PostPosted: Sun Nov 12, 2006 10:07 pm 
Offline
Family Member
User avatar

Joined: Sat Nov 11, 2006 4:00 pm
Posts: 63
Researchers Closer To Cure For Multiple Sclerosis And Other Myelin-related Diseases
06 Nov 2006

A breakthrough finding on the mechanism of myelin formation by Jonah Chan, assistant professor of cell and neurobiology at the Keck School of Medicine of the University of Southern California, could have a major impact on the treatment of diseases such as multiple sclerosis and demyelination as a result of spinal cord injuries.

Myelin, the white matter that coats all nerves, allows long-distance communication in the nervous system. "It plays a vital role in the overall health and function of the nervous system, and its degeneration plays a role in a number of diseases, such as multiple sclerosis, peripheral neuropathies, and even in spinal cord injury," Chan explained.

The study, "The Polarity Protein Par-3 Directly Interacts with p75NTR to Regulate Myelination", appears in the Nov. 3 issue of Science. Chan, who works at the Zilkha Neurogenetic Institute at the Keck School of Medicine of USC, collaborated on the study with Michel Cayouette and researchers at the Institut de Recherches Cliniques de Montreal in Canada.

At a basic level, the nervous system functions like a collection of wires that transmit electrical signals encoding our thoughts, feelings, and actions. Just as an electrical wire needs insulation, myelin is wrapped around axons - the wire-like extensions of neurons that make up nerve fibers. The sheath helps to propagate the electrical signal and maximize the efficiency and velocity of these signals in our brain and body.

Diseases and injuries that compromise the integrity of myelin, such as multiple sclerosis or peripheral neuropathies, have dramatic consequences like paralysis, uncoordinated movements, and neuropathic pain.

Chan's study sheds light on the mechanisms that control how myelin is formed during development of the nerves. The article constitutes an important step forward in understanding the process of myelination and opens the way to new research in this field.

Chan showed that a protein, Par-3, is at the base of the myelination process. This protein becomes localized to one side of the myelin-forming cells, known as Schwann cells, upon contact with the axon that is to be myelinated. Par-3 acts almost as a molecular scaffold to set-up an "organizing centre", which brings together key proteins essential for myelination, in particular a receptor for a molecule secreted by the neurons.

The researchers found that when they disrupted this organizing centre, cells could not form myelin normally. Importantly, their discovery demonstrates that Schwann cells need to become polarized so that they know which side is in contact with the axon to initiate wrapping and to bring essential molecules to this critical interface.

These studies open the way to new research, said Chan, which should help to identify other components that are recruited at the organizing center set-up by Par-3. In multiple sclerosis, or after injury, Schwann cells can re-myelinate axons of the central nervous system to some degree. Therefore, these experiments bring about the possibility that manipulating the Par-3 pathway might allow for more efficient re-myelination of damaged or diseased nerves.

This work was supported by the National Multiple Sclerosis Society Career Transition Award and the Donald E. and Delia B. Baxter Foundation Award to Jonah Chan, and the Canadian Institute of Health Research to Michel Cayouette.

Chan, J. R., Jolicoeur, C., Yamauchi, J, Elliott, J, Fawcett, J. P., Ng, B. K., and Cayouette, M. ,"The Polarity Protein Par-3 Directly Interacts with p75NTR to Regulate Myelination," Science, Nov. 3, 2006.

University of Southern California
1975 Zonal Ave., #400
Los Angeles, CA 90033
United States

http://www.usc.edu/hsc/info/pr/index.html

Article URL:

http://www.medicalnewstoday.com/medical ... wsid=55920


Top
 Profile  
 
 Post subject:
PostPosted: Mon Nov 13, 2006 3:52 am 
Offline
Volunteer Moderator
User avatar

Joined: Sat Nov 20, 2004 4:00 pm
Posts: 2706
Quote:
These studies open the way to new research, said Chan, which should help to identify other components that are recruited at the organizing center set-up by Par-3. In multiple sclerosis, or after injury, Schwann cells can re-myelinate axons of the central nervous system to some degree. Therefore, these experiments bring about the possibility that manipulating the Par-3 pathway might allow for more efficient re-myelination of damaged or diseased nerves.

Interesting article. However, to the best of my knowledge, myelin in the central nervous system is formed by oligodendrocytes not schwann cells.

NHE


Top
 Profile  
 
 Post subject:
PostPosted: Mon Nov 13, 2006 4:03 am 
Offline
Family Elder
User avatar

Joined: Wed Jul 27, 2005 3:00 pm
Posts: 2684
Location: Sydney, Australia
The following article got me excited, then I read the date. 2004. And Still no "drug designed"

Quote:
Researchers at the School of Medicine have just discovered an unexpected new type of lock-and-key mechanism that provides a critical step in reproducing nerve growth factor, crucial to all aspects of nerve formation and function.

The information revealed can now be directly applied to design a drug to treat neurodegenerative conditions such as Alzheimer's disease or spinal cord injuries.
my emphasis.
http://news-service.stanford.edu/news/medical/2004/may26/nerve.html


Top
 Profile  
 
 Post subject:
PostPosted: Mon Nov 13, 2006 4:48 am 
Offline
Family Elder
User avatar

Joined: Fri Sep 10, 2004 3:00 pm
Posts: 1889
NHE,

Quote:
Interesting article. However, to the best of my knowledge, myelin in the central nervous system is formed by oligodendrocytes not schwann cells.


You are right - but trials have been undertaken to transplant schwann cells into the CNS. The first trial didn't appear to be a success and I haven't seen any updates recently.

Ian


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 4 posts ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Researchers developing new oral Multiple Sclerosis drug

squiffy2

0

289

Wed Jul 11, 2012 1:23 am

squiffy2 View the latest post

There are no new unread posts for this topic. Could I have Multiple Sclerosis?

estelsoto29

3

473

Thu Oct 18, 2012 6:08 pm

lyndacarol View the latest post

There are no new unread posts for this topic. Multiple Sclerosis UK

squiffy2

0

237

Thu Feb 07, 2013 1:54 am

squiffy2 View the latest post

There are no new unread posts for this topic. Multiple Sclerosis Alternatives

Dudley

1

1873

Thu Feb 17, 2005 11:53 am

LindaR View the latest post

There are no new unread posts for this topic. Alexithymia in multiple sclerosis

Thomas

0

1215

Sat Dec 29, 2007 11:11 am

Thomas View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: